Private Equity in Medicare Delivery
Accountability, Quality, and the Care Model Question
Private equity has become one of the largest ownership categories in Medicare-dependent healthcare delivery. The investment thesis is straightforward: Medicare payment streams are predictable, utilization is growing as the population ages, and a fragmented delivery landscape creates roll-up opportunities where scale produces operating leverage. The capital flows in. Physician practices, home health agencies, hospices, skilled nursing facilities, behavioral health providers, urgent care chains, and dental groups are acquired, consolidated, and optimized for financial return within a three-to-seven-year hold period. The question this article examines is whether the PE ownership model, characterized by leveraged acquisition, cost reduction as a primary margin driver, rapid growth through consolidation, and exit through sale or IPO, is compatible with the quality, continuity, and accessibility that Medicare beneficiaries need from the providers who care for them.
The question is not abstract. The peer-reviewed evidence base has grown substantially in the past three years, and it points in a consistent direction. The bipartisan Senate Budget Committee investigation produced a report in January 2025 documenting how two PE firms extracted profits from hospitals while increasing their debt and allowing patient care to deteriorate. A multiagency HHS report issued the same month cataloged the mechanisms through which PE ownership affects care delivery. The research, the congressional attention, and the enforcement activity are converging at the same moment that the MA rate compression documented in this series is forcing plans and providers to find new operating models, some of which involve PE capital.
The Scale of PE Investment#
PE capital has concentrated in Medicare-dependent delivery sectors where fragmentation creates acquisition opportunity and Medicare payment mechanisms create predictable revenue.
Physician staffing is among the most deeply PE-penetrated sectors. Emergency medicine, anesthesiology, radiology, and hospitalist medicine have experienced waves of PE-backed consolidation. In some markets, PE firms control more than half of emergency department staffing. The physician staffing model generates revenue through FFS billing for professional services, and the PE playbook involves acquiring practices, consolidating contracts with hospitals, negotiating higher facility fees, and managing physician compensation as a cost variable that can be adjusted to improve margin.
Home health and hospice have attracted substantial PE investment because of Medicare’s payment structures: home health operates under a prospective payment system that creates per-episode revenue predictability, and hospice operates under per-diem reimbursement that generates revenue proportional to length of enrollment. PE-owned entities now account for a significant and growing share of both sectors. Nearly one-third of hospices with the lowest spending on direct patient care are PE-owned, according to analysis cited in the Center for American Progress’s 2025 report on PE in healthcare.
Skilled nursing facilities and post-acute care represent another concentration. The National Bureau of Economic Research published findings that the 90-day mortality rate for Medicare patients was 10% higher in PE-owned nursing homes than in other skilled nursing facilities, a finding that directly connects the ownership model to patient survival. Behavioral health, urgent care, and dental have also experienced PE consolidation, though with less Medicare-specific data available because these sectors serve a more mixed-payer population.
The total Medicare revenue flowing through PE-owned entities is difficult to quantify precisely because corporate ownership structures are often opaque, with PE firms holding portfolio companies through multiple layers of holding companies, management services organizations, and affiliated entities. CMS’s corporate ownership disclosure requirements have historically been insufficient to trace the chain from the PE fund through its portfolio company to the individual provider billing Medicare. This transparency gap is itself a policy problem, because regulators cannot effectively oversee what they cannot see.
Quality Outcomes Under PE Ownership#
The peer-reviewed evidence on quality outcomes in PE-owned healthcare facilities has reached a volume and consistency that makes the pattern difficult to dismiss.
The landmark 2023 JAMA study by Kannan, Bruch, and Song analyzed 100% Medicare Part A claims for 662,095 hospitalizations at 51 PE-acquired hospitals compared with 4,160,720 hospitalizations at 259 matched control hospitals from 2009 to 2019. The findings: Medicare beneficiaries admitted to PE hospitals experienced a 25.4% increase in hospital-acquired conditions compared to control hospitals. The increase was driven by a 27.3% rise in falls and a 37.7% increase in central line-associated bloodstream infections, despite PE hospitals placing 16.2% fewer central lines. Surgical site infections doubled at PE hospitals despite an 8.1% reduction in surgical volume.
A 2025 follow-up study by the same research team, published in the Annals of Internal Medicine, examined staffing and patient outcomes in EDs and ICUs after PE acquisition. PE hospitals reduced ED salary expenditures by 18.2% and ICU salary expenditures by 15.9%, alongside hospital-wide reductions in full-time employees of 11.6% and salary expenditures of 16.6%. Medicare beneficiaries in PE hospital EDs experienced 7.0 additional deaths per 10,000 visits after acquisition, a 13.4% increase. ICU patients experienced a 4.2% increase in transfers to other hospitals, and ICU length of stay shortened by 0.2 days, patterns consistent with reduced capacity forcing sicker patients out of the facility.
A separate 2024 JAMA study found that hospital assets decreased by 24% in the two years after PE acquisition, equivalent to approximately $28 million in total assets per hospital, reflecting the sale of land, buildings, equipment, and information technology. A February 2025 JAMA study on patient experience documented declines in patient satisfaction measures after PE acquisition. A 2025 Health Affairs study found that PE-owned physician practices decreased access to retinal detachment surgery by nearly 20%, a finding with direct clinical consequence because delayed retinal surgery causes irreversible vision loss.
The staffing reduction pattern is the mechanism that connects PE ownership to clinical outcomes. The PE cost management model treats labor as the primary variable cost. Reducing headcount, substituting lower-cost staff for higher-cost staff (replacing RNs with non-RN staff, for example), and shortening shifts to reduce overtime are standard PE operating playbook elements. In clinical settings, staffing levels are directly correlated with patient safety. Falls increase when there are fewer nurses per patient. Infections increase when infection control protocols are compressed by time pressure. Mortality increases in EDs when the physician and nursing staff cannot evaluate and stabilize patients fast enough. The evidence base does not show that PE ownership causes bad intentions. It shows that the cost reduction imperative of the PE model, applied to clinical settings where staffing levels are safety-critical, produces measurable patient harm.
The hospice quality differential deserves specific attention because hospice is a growing component of Medicare spending with significant PE penetration. PE-owned hospices have documented higher rates of long stays (suggesting enrollment of patients who are not truly terminal), higher rates of live discharge (further suggesting inappropriate enrollment), and lower staffing ratios than nonprofit hospice providers. These patterns intersect with the hospice FWA dynamics documented in MCR-04.10: length-of-stay manipulation and enrollment of ineligible beneficiaries are both fraud vectors and quality indicators, because a patient enrolled in hospice who does not meet terminal illness criteria is simultaneously an improper payment and a person receiving care misaligned with their clinical status (MCR-05.12).
The Medicare Payment Structure as PE Thesis#
PE’s concentration in Medicare-dependent sectors is not random. It reflects a deliberate investment thesis built around Medicare’s payment design, and different payment mechanisms create different PE playbooks.
Cost-based and prospective payment systems in home health and SNF create a cost inflation incentive. Medicare pays per episode (home health) or per day (SNF), and the revenue is largely fixed regardless of how the provider manages costs within the episode or stay. The PE playbook in these settings involves reducing staffing and supply costs to widen the gap between fixed revenue and variable cost. The margin improvement flows to the PE fund as return on investment. The patient absorbs the quality consequence of reduced staffing and resources.
FFS payment in physician services creates a volume incentive. Medicare pays per service rendered, and the PE playbook in physician staffing involves maximizing the volume of billable services per physician, optimizing coding to ensure each encounter is billed at the highest defensible complexity level, and negotiating facility fee arrangements with hospitals that generate additional revenue per encounter. The coding and billing intensity that PE-owned physician practices demonstrate is a feature of the model, not a bug: the investment thesis depends on revenue optimization per clinical encounter.
MA capitation creates a risk adjustment optimization incentive. PE-backed entities that contract with MA plans to provide care for capitated populations have a financial interest in maximizing the risk scores of their attributed patients, because higher risk scores generate higher capitation. The chart review, CDI, and HRA practices that the risk adjustment reform agenda targets (MCR-02.02, MCR-02.04) are practices in which PE-owned provider organizations participate. Whether PE ownership correlates with more aggressive coding practices than non-PE providers is an empirical question that the current data does not conclusively answer, but the incentive structure and the PE model’s emphasis on financial performance metrics create conditions favorable to aggressive coding.
The Competitive Landscape for Non-PE Providers#
Independent practices and health systems face PE-backed competitors with access to growth capital, acquisitive scale, and physician recruitment infrastructure that non-PE entities cannot easily match.
PE-backed physician staffing firms control emergency department, anesthesiology, and hospitalist contracts at hospitals across the country. When a hospital’s ED staffing contract is held by a PE-owned firm, the hospital’s ability to influence clinical staffing levels, quality metrics, and patient experience is constrained by the terms of the contract. Independent emergency medicine groups that compete for those contracts face a PE competitor willing to offer the hospital a lower contract price because the PE firm can reduce costs through staffing optimization that an independent group, which must maintain physician satisfaction and retention, cannot replicate.
Physician recruitment operates through the same dynamic. PE-backed organizations can offer higher initial compensation packages, signing bonuses, and practice support infrastructure that attract physicians away from independent practices and health systems. The physician joins a PE-owned practice with guaranteed income, and the PE firm recovers the investment through volume expectations, coding optimization, and the eventual sale of the consolidated practice platform at a higher valuation.
The strategic response for non-PE providers involves three pathways. Independent practices can consolidate with each other to achieve scale, negotiating leverage, and recruitment competitiveness without PE capital. Health systems can acquire physician practices to bring them inside the system’s organizational structure, protecting them from PE acquisition and integrating them into the system’s clinical and financial infrastructure. And provider-sponsored plans and payvider models offer a structural counter: a health system that owns both the delivery system and the MA plan can compete for enrollment on the basis of clinical integration and care quality rather than on the cost reduction that PE-optimized competitors pursue (MCR-05.02, MCR-05.10).
Regulatory and Legislative Responses#
The policy response to PE in healthcare is emerging but remains fragmented across state and federal jurisdictions.
At the state level, legislative proposals targeting PE in healthcare have proliferated. Several states have enacted or are considering laws requiring advance notice of healthcare facility acquisitions by PE firms, mandating disclosure of corporate ownership structures, imposing staffing ratio requirements that constrain PE cost reduction strategies, and requiring independent assessments of the acquisition’s impact on community access and quality before regulatory approval. The specifics vary by state, and enforcement capacity varies even more. State insurance departments and health departments that review these transactions are often under-resourced relative to the volume and complexity of PE deals.
At the federal level, CMS finalized corporate ownership disclosure requirements that require Medicare-enrolled providers to report their ownership structure, including PE ownership, to CMS. The bipartisan Senate Budget Committee report in January 2025 documented the consequences of PE hospital ownership in detail and called into question the compatibility of PE’s profit-driven model with hospitals’ public health role. The Senate investigation provides the evidentiary foundation for legislation, though whether the 119th Congress acts on it depends on legislative bandwidth and the political dynamics of healthcare reform during a period dominated by reconciliation and other priorities.
The enforcement gap is real. Existing regulatory tools, state licensing requirements, CMS conditions of participation, accreditation standards, and quality reporting programs, were not designed to address the specific risks PE ownership creates. A PE firm that acquires a hospital, extracts its assets through a sale-leaseback, loads the hospital with debt, reduces staffing, and exits through a sale to another PE firm has not violated any single regulatory standard at any discrete point in the process. The harm is cumulative and structural, and the regulatory framework operates transaction by transaction rather than across the ownership lifecycle. Closing this gap requires either new legislation specifically targeting PE ownership practices in healthcare or a regulatory framework that evaluates the cumulative impact of ownership changes on facility viability, staffing adequacy, and patient outcomes over time.
The PE question intersects with the MA market consolidation dynamics this series documents (MCR-04.08). As MA rate compression forces plans to find lower-cost delivery partners, PE-owned provider organizations that offer lower contract prices may become more attractive to plans seeking to reduce MLR. The quality trade-off embedded in that decision, choosing a lower-cost PE provider whose staffing and quality metrics may be worse than the independent or system-affiliated alternative, is the operational expression of the tension between plan financial survival and beneficiary care quality that defines the payer’s dilemma.
Related Reading#
MCR-05_10 Private Equity and the Medicare Delivery System: What Providers Need to Know MCR-12_02 Health System Winners and Losers: Kaiser, Intermountain, UPMC, Advocate, Geisinger